Federal Register / Vol. 69, No. 24 / Thursday, February 5, 2004 / Notices 5559

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Conference 

Room 6C10, Bethesda, MD 20892. 

Contact Person: Anne P. Sassaman, PhD, 

Director, Division of Extramural Research 

and Training, National Institute of 

Environmental Health Sciences, National 

Institutes of Health, P.O. Box 12233, 

Research Triangle Park, NC 27709, 929/541–

7723. 

Information is also available on the 

Institute’s/Center’s home page: http://

www.niehs.nih.gov/dert/c-agenda.htm, where 

an agenda and any additional information for 

the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.115, Biometry and Risk 

Estimation—Health Risks from 

Environmental Exposures; 93.142, NIEHS 

Hazardous Waste Worker Health and Safety 

Training; 92.143, NIEHS Superfund 

Hazardous Substances—Basic Research and 

Education; 93.894, Resources and Manpower 

Development in the Environmental Health 

Sciences; 93.113, Biological Response to 

Environmental Health Hazards, 93.114, 

Applied Toxicological Research and Testing, 

National Institutes of Health, HHS)

Dated: January 29, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–2383 Filed 2–4–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Deafness and 

Other Communication Disorders; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: Communication 

Disorders Review Committee, 

Communication Disorders Review 

Committee. 

Date: February 18–19, 2004. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Melissa J. Stick, PhD, 

MPH, Scientific Review Administrator, 

Scientific Review Branch, Division of 

Extramural Research, NIDCD/NIH, 6120 

Executive Blvd., Bethesda, MD 20892. 301–

496–8683. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.173, Biological Research 

Related to Deafness and Communicative 

Disorders, National Institutes of Health, 

HHS.)

Dated: January 29, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–2384 Filed 2–4–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Deafness and 

Other Communication Disorders; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Institute on 

Deafness and Other Communications 

Disorders Special Emphasis Panel, NIDCD 

Training, Career Development and 

Conference Grant Review. 

Date: March 1, 2004. 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6120 

Executive Blvd., Rockville, MD 20852. 

Contact Person: Ali A. Azadegan, DVM, 

PhD, Scientific Review Administrator, 

Scientific Review Branch, Division of 

Extramural Activities, NIDCD, NIH, EPS–

400C, 6120 Executive Blvd. MSC 7180, 

Bethesda, MD 20892–7180. (301) 496–8683; 

azadegan@nih.gov.

Name of Committee: National Institute on 

Deafness and Other Communications 

Disorders Special Emphasis Panel, Review of 

NIDCD Clinical Centers. 

Date: March 2, 2004. 

Time: 9 a.m. to 11 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, EPS/

400C, 6120 Executive Blvd., Rockville, MD 

20852. 

Contact Person: Melissa Stick, PhD, MPH, 

Scientific Review Administrator, Scientific 

Review Branch, Division of Extramural 

Activities, NIDCD/NIH, 6120 Executive 

Blvd., Bethesda, MD 20892. (301) 496–8683.

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.173, Biological Research 

Related to Deafness and Communicative 

Disorders, National Institutes of Health, 

HHS.)

Dated: January 29, 2004. 

LaVerne Y. Stringfield, 

Director, Office of Federal Advisory 

Committee Policy.

[FR Doc. 04–2385 Filed 2–4–04; 8:45 am] 

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Drug Abuse; 

Notice of Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy.

Name of Committee: National Institute on 

Drug Abuse Special Emphasis Panel, SBIR—

‘‘Develop New Technologies for Screening 

andAssessing Drug Abuse and Matching 

Patients with Appropriate Treatment 

Services’’ (Topic 060). 

Date: February 3, 2004. 

Time: 9 a.m. to 4 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: Double Tree Rockville, 1750 

Rockville Pike, Rockville, MD 20852. 

Contact Person: Lyle Furr, Contract Review 

Specialist, Office of Extramural Affairs, 

National Institute on Drug Abuse, NIH, 

DHHS, Room 220, MSC 8401, 6101 Executive